Meclizine Hcl Tablet
FDA Label NDC 57237-333

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Rising Pharma Holdings, Inc. for the product Meclizine Hcl (NDC 57237-333). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding drug facts active ingredient (in each tablet), purpose, uses, warnings, when using this product, otc - pregnancy or breast feeding, otc - keep out of reach of children, directions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Other

Manufactured by:
Unique Pharmaceutical Laboratories
(A Div. of J.B.Chemicals &
Pharmaceuticals Ltd.),
Mumbai 400 030, India

Mfg. Lic. No.: G/1430

Distributed by:
Rising Pharma Holdings, Inc.
East Brunswick, NJ 08816

Issued: 02/2024

138528

* Please review the disclaimer below.